BioCentury | Jan 2, 2012
Finance

Enriched by Enobia

...investors in the Montreal-based company, Fonds de solidarite FTQ; Desjardins Venture Capital; Lothian Partners; and T2C2/Bio 2000...
BioCentury | Jul 31, 2008
Company News

Cytochroma, Mitsubishi Tanabe in CTA018 deal

...investors VenGrowth; Caisse de Depot et Placement du Quebec; Novo A/S; Canadian Medical Discoveries Fund; T2C2...
BioCentury | Sep 12, 2007
Financial News

Enobia raises US$38 million

...Life Sciences Fund. Existing investors Fonds de solidarite FTQ; Desjardins Venture Capital; Lothian Partners; and T2C2/Bio 2000...
BioCentury | Aug 20, 2007
Finance

Ebb & Flow

...existing investors BDC Venture Capital; Desjardins Venture Capital; Caisse de Depot et Placement du Quebec; T2C2...
BioCentury | Aug 16, 2007
Financial News

Topigen raises $24.7 million

...existing investors BDC Venture Capital; Desjardins Venture Capital; Caisse de Depot et Placement du Quebec; T2C2...
BioCentury | Mar 7, 2007
Financial News

PainCeptor raises C$24.4 million

...million (US$20.8 million) in a series B round. Investors included Desjardins Venture Capital; CDP Capital; T2C2/Bio 2000...
BioCentury | Oct 30, 2006
Finance

Ebb & Flow

...investor CDC Enterprises Innovation, with participation from existing investors Axa Private Equity; BioAm; Credit Agricole; T2C2...
BioCentury | Oct 26, 2006
Financial News

Cytheris raises EUR 24.3 million

...Enterprises Innovation. New investor ABN AMRO joined existing investors Axa Private Equity; BioAm; Credit Agricole; T2C2...
BioCentury | Jul 25, 2006
Financial News

TransPharma raises $18 million

...round led by Argonaut . New investor Teva (TEVA) joined existing investors Pitango; Evergreen Partners; T2C2...
BioCentury | May 2, 2005
Emerging Company Profile

Corporate Profile

...McGill University Number of employees: 29 Funds raised: C$29.2 million (US$24.6 million) Investors: FTQ Fund; T2C2/Bio 2000...
Items per page:
1 - 10 of 23
BioCentury | Jan 2, 2012
Finance

Enriched by Enobia

...investors in the Montreal-based company, Fonds de solidarite FTQ; Desjardins Venture Capital; Lothian Partners; and T2C2/Bio 2000...
BioCentury | Jul 31, 2008
Company News

Cytochroma, Mitsubishi Tanabe in CTA018 deal

...investors VenGrowth; Caisse de Depot et Placement du Quebec; Novo A/S; Canadian Medical Discoveries Fund; T2C2...
BioCentury | Sep 12, 2007
Financial News

Enobia raises US$38 million

...Life Sciences Fund. Existing investors Fonds de solidarite FTQ; Desjardins Venture Capital; Lothian Partners; and T2C2/Bio 2000...
BioCentury | Aug 20, 2007
Finance

Ebb & Flow

...existing investors BDC Venture Capital; Desjardins Venture Capital; Caisse de Depot et Placement du Quebec; T2C2...
BioCentury | Aug 16, 2007
Financial News

Topigen raises $24.7 million

...existing investors BDC Venture Capital; Desjardins Venture Capital; Caisse de Depot et Placement du Quebec; T2C2...
BioCentury | Mar 7, 2007
Financial News

PainCeptor raises C$24.4 million

...million (US$20.8 million) in a series B round. Investors included Desjardins Venture Capital; CDP Capital; T2C2/Bio 2000...
BioCentury | Oct 30, 2006
Finance

Ebb & Flow

...investor CDC Enterprises Innovation, with participation from existing investors Axa Private Equity; BioAm; Credit Agricole; T2C2...
BioCentury | Oct 26, 2006
Financial News

Cytheris raises EUR 24.3 million

...Enterprises Innovation. New investor ABN AMRO joined existing investors Axa Private Equity; BioAm; Credit Agricole; T2C2...
BioCentury | Jul 25, 2006
Financial News

TransPharma raises $18 million

...round led by Argonaut . New investor Teva (TEVA) joined existing investors Pitango; Evergreen Partners; T2C2...
BioCentury | May 2, 2005
Emerging Company Profile

Corporate Profile

...McGill University Number of employees: 29 Funds raised: C$29.2 million (US$24.6 million) Investors: FTQ Fund; T2C2/Bio 2000...
Items per page:
1 - 10 of 23